You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dabigatran: how the drug company withheld important analyses
|
|---|---|
| Published in |
British Medical Journal, July 2014
|
| DOI | 10.1136/bmj.g4670 |
| Pubmed ID | |
| Authors |
Deborah Cohen |
X Demographics
The data shown below were collected from the profiles of 509 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 64 | 13% |
| United States | 54 | 11% |
| United Kingdom | 37 | 7% |
| Australia | 26 | 5% |
| Canada | 18 | 4% |
| Ireland | 13 | 3% |
| Colombia | 11 | 2% |
| Argentina | 9 | 2% |
| Chile | 6 | 1% |
| Other | 67 | 13% |
| Unknown | 204 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 369 | 72% |
| Practitioners (doctors, other healthcare professionals) | 75 | 15% |
| Scientists | 51 | 10% |
| Science communicators (journalists, bloggers, editors) | 12 | 2% |
| Unknown | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| Denmark | 2 | 1% |
| Spain | 2 | 1% |
| Austria | 1 | <1% |
| Egypt | 1 | <1% |
| Brazil | 1 | <1% |
| Italy | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 141 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 20% |
| Other | 20 | 13% |
| Professor > Associate Professor | 16 | 10% |
| Student > Master | 14 | 9% |
| Student > Bachelor | 14 | 9% |
| Other | 40 | 26% |
| Unknown | 18 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 64% |
| Agricultural and Biological Sciences | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Business, Management and Accounting | 3 | 2% |
| Nursing and Health Professions | 3 | 2% |
| Other | 10 | 7% |
| Unknown | 22 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 459. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2023.
All research outputs
#60,616
of 25,728,855 outputs
Outputs from British Medical Journal
#1,081
of 64,982 outputs
Outputs of similar age
#427
of 240,531 outputs
Outputs of similar age from British Medical Journal
#5
of 596 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 64,982 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,531 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 596 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.